These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 19933409)

  • 1. B-type natriuretic peptide testing and the accuracy of heart failure diagnosis in the emergency department.
    Lokuge A; Lam L; Cameron P; Krum H; de Villiers S; Bystrzycki A; Naughton MT; Eccleston D; Flannery G; Federman J; Schneider HG
    Circ Heart Fail; 2010 Jan; 3(1):104-10. PubMed ID: 19933409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.
    Chung T; Sindone A; Foo F; Dwyer A; Paoloni R; Janu MR; Wong H; Hall J; Freedman SB
    Am Heart J; 2006 Nov; 152(5):949-55. PubMed ID: 17070166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The combined utility of an S3 heart sound and B-type natriuretic peptide levels in emergency department patients with dyspnea.
    Collins SP; Lindsell CJ; Peacock WF; Hedger VD; Askew J; Eckert DC; Storrow AB
    J Card Fail; 2006 May; 12(4):286-92. PubMed ID: 16679262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study.
    Daniels LB; Clopton P; Bhalla V; Krishnaswamy P; Nowak RM; McCord J; Hollander JE; Duc P; Omland T; Storrow AB; Abraham WT; Wu AH; Steg PG; Westheim A; Knudsen CW; Perez A; Kazanegra R; Herrmann HC; McCullough PA; Maisel AS
    Am Heart J; 2006 May; 151(5):999-1005. PubMed ID: 16644321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of history of heart failure on diagnostic and prognostic value of BNP: results from the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation (BASEL) study.
    Boldanova T; Noveanu M; Breidthardt T; Potocki M; Reichlin T; Taegtmeyer A; Christ M; Laule K; Stelzig C; Mueller C
    Int J Cardiol; 2010 Jul; 142(3):265-72. PubMed ID: 19185372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of aminoterminal pro-brain natriuretic peptide testing for the diagnostic and prognostic evaluation of dyspneic patients with diabetes mellitus seen in the emergency department (from the PRIDE Study).
    O'Donoghue M; Kenney P; Oestreicher E; Anwaruddin S; Baggish AL; Krauser DG; Chen A; Tung R; Cameron R; Januzzi JL
    Am J Cardiol; 2007 Nov; 100(9):1336-40. PubMed ID: 17950786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure.
    Mueller T; Gegenhuber A; Poelz W; Haltmayer M
    Heart; 2005 May; 91(5):606-12. PubMed ID: 15831643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea.
    Pahle AS; Sørli D; Omland T; Knudsen CW; Westheim A; Wu AH; Steg PG; McCord J; Nowak RM; Hollander JE; Storrow AB; Abraham WT; McCullough PA; Maisel A
    Am J Cardiol; 2009 Oct; 104(7):966-71. PubMed ID: 19766765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation.
    Maisel AS; Peacock WF; Shah KS; Clopton P; Diercks D; Hiestand B; Kontos MC; Mueller C; Nowak R; Chen WJ; Collins SP
    Am J Emerg Med; 2011 Oct; 29(8):924-31. PubMed ID: 20627217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of B-type natriuretic peptide and anemia in patients with and without heart failure: a substudy from the Breathing Not Properly (BNP) Multinational Study.
    Wu AH; Omland T; Wold Knudsen C; McCord J; Nowak RM; Hollander JE; Duc P; Storrow AB; Abraham WT; Clopton P; Maisel AS; McCullough PA;
    Am J Hematol; 2005 Nov; 80(3):174-80. PubMed ID: 16247751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the plasma brain natriuretic peptide in differentiating patients with congestive heart failure from other diseases.
    Sirithunyanont C; Leowattana W; Sukumalchantra Y; Chaisupamonkollarp S; Watanawaroon S; Chivatanaporn B; Bhuripanyo K; Mahanonda N
    J Med Assoc Thai; 2003 May; 86 Suppl 1():S87-95. PubMed ID: 12866774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparable increase of B-type natriuretic peptide and amino-terminal pro-B-type natriuretic peptide levels in patients with severe sepsis, septic shock, and acute heart failure.
    Rudiger A; Gasser S; Fischler M; Hornemann T; von Eckardstein A; Maggiorini M
    Crit Care Med; 2006 Aug; 34(8):2140-4. PubMed ID: 16763507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Admission B-type natriuretic peptide levels and in-hospital mortality in acute decompensated heart failure.
    Fonarow GC; Peacock WF; Phillips CO; Givertz MM; Lopatin M;
    J Am Coll Cardiol; 2007 May; 49(19):1943-50. PubMed ID: 17498579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of NT-proBNP testing on diagnostic certainty in patients admitted to the emergency department with possible heart failure.
    Robaei D; Koe L; Bais R; Gould I; Stewart T; Tofler GH
    Ann Clin Biochem; 2011 May; 48(Pt 3):212-7. PubMed ID: 21398433
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the diagnostic characteristics of two B-type natriuretic peptide point-of-care devices.
    Ro R; Thode HC; Taylor M; Gulla J; Tetrault E; Singer AJ
    J Emerg Med; 2011 Dec; 41(6):661-7. PubMed ID: 21620610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea.
    Rogers RK; Stoddard GJ; Greene T; Michaels AD; Fernandez G; Freeman A; Nord J; Stehlik J
    Am J Cardiol; 2009 Sep; 104(5):689-94. PubMed ID: 19699346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [B-type natriuretic peptide and clinical judgement in the diagnosis of heart failure in patients presenting with acute dyspnoea].
    Knudsen CW; Westheim A; Omland T
    Tidsskr Nor Laegeforen; 2003 Aug; 123(15):2045-8. PubMed ID: 12934128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: a ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) substudy.
    Krauser DG; Lloyd-Jones DM; Chae CU; Cameron R; Anwaruddin S; Baggish AL; Chen A; Tung R; Januzzi JL
    Am Heart J; 2005 Apr; 149(4):744-50. PubMed ID: 15990762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of B-type natriuretic peptide levels < 100 pg/mL in patients with heart failure at hospital discharge.
    Hogenhuis J; Voors AA; Jaarsma T; Hillege HL; Hoes AW; van Veldhuisen DJ
    Am Heart J; 2006 May; 151(5):1012.e1-5. PubMed ID: 16644323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.